GLP-1 medications can cause side effects such as nausea, constipation, fatigue, reflux, or appetite changes, especially during dose escalation
The critical difference from patches is the delivery route
Furthermore, the homeostasis of bone formation and resorption is essential to bone health and might be maintained by GLP-1 in normal bones and restored by GLP-1 in unhealthy bones
Potentially, pharmacological enhancement of incretin secretion could bridge the gap between RYGB and LAGB on body weight and diabetes-related outcomes
GLP-1 agonist Liraglutide prevents MK801-induced schizophrenialike behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice